Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Tumor necrosis factor alpha inhibitor | Is a | biologisk produkt | false | Inferred relationship | Some | ||
Tumor necrosis factor alpha inhibitor | Is a | Immunomodulator | true | Inferred relationship | Some | ||
Tumor necrosis factor alpha inhibitor | Is a | antiinflammatoriskt läkemedel | false | Inferred relationship | Some | ||
Tumor necrosis factor alpha inhibitor | Has disposition (attribute) | Tumor necrosis factor alpha inhibitor (disposition) | true | Inferred relationship | Some | ||
Tumor necrosis factor alpha inhibitor | Is a | Drug or medicament (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Adalimumab (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
Infliximab (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
Etanercept (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
Product containing tumor necrosis factor alpha inhibitor (product) | Has active ingredient | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | 1 |
Certolizumab pegol (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
Golimumab | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some |
Reference Sets